{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T02:15:20Z","timestamp":1773886520696,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s10157-019-01769-8","type":"journal-article","created":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T10:03:02Z","timestamp":1564653782000},"page":"1323-1330","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Risk factors and incidence of malignant neoplasms after kidney transplantation at a single institution in Japan"],"prefix":"10.1007","volume":"23","author":[{"given":"Kengo","family":"Horie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Iinuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Nakane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taku","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Koie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,1]]},"reference":[{"key":"1769_CR1","unstructured":"Yoshida K. Fact book 2017 of organ transplantation in Japan. 2017.\u00a0\n                    http:\/\/www.asas.or.jp\/jst\/pdf\/factbook\/factbook2017.pdf"},{"issue":"9218","key":"1769_CR2","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1016\/S0140-6736(00)02298-4","volume":"355","author":"SA Birkeland","year":"2000","unstructured":"Birkeland SA, L\u2298kkegaard H, Storm HH. Cancer risk in patients on dialysis and after renal transplantation. Lancet. 2000;355(9218):1886\u20137. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(00)02298-4\n                    \n                  .","journal-title":"Lancet"},{"issue":"2","key":"1769_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1053\/rr.2000.5269","volume":"7","author":"I Penn","year":"2000","unstructured":"Penn I. Cancers in renal transplant recipients. Adv Renal Replace Ther. 2000;7(2):147\u201356. \n                    https:\/\/doi.org\/10.1053\/rr.2000.5269\n                    \n                  .","journal-title":"Adv Renal Replace Ther."},{"key":"1769_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfy262","author":"CY Cheung","year":"2018","unstructured":"Cheung CY, Tang SCW. An update on cancer after kidney transplantation. Nephrol Dial Transpl. 2018. \n                    https:\/\/doi.org\/10.1093\/ndt\/gfy262\n                    \n                  .","journal-title":"Nephrol Dial Transpl."},{"issue":"1","key":"1769_CR5","first-page":"773","volume":"3","author":"I Penn","year":"1971","unstructured":"Penn I, Halgrimson CG, Starzl TE. De novo malignant tumors in organ transplant recipients. Transpl Proc. 1971;3(1):773\u20138.","journal-title":"Transpl Proc."},{"issue":"6","key":"1769_CR6","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/j.1600-6143.2004.00450.x","volume":"4","author":"BL Kasiske","year":"2004","unstructured":"Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transpl. 2004;4(6):905\u201313. \n                    https:\/\/doi.org\/10.1111\/j.1600-6143.2004.00450.x\n                    \n                  .","journal-title":"Am J Transpl."},{"issue":"10","key":"1769_CR7","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1002\/cncr.22636","volume":"109","author":"T Imao","year":"2007","unstructured":"Imao T, Ichimaru N, Takahara S, Kokado Y, Okumi M, Imamura R, et al. Risk factors for malignancy in Japanese renal transplant recipients. Cancer. 2007;109(10):2109\u201315. \n                    https:\/\/doi.org\/10.1002\/cncr.22636\n                    \n                  .","journal-title":"Cancer"},{"issue":"11","key":"1769_CR8","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1111\/j.1600-6143.2008.02385.x","volume":"8","author":"AC Webster","year":"2008","unstructured":"Webster AC, Wong G, Craig JC, Chapman JR. Managing cancer risk and decision making after kidney transplantation. Am J Transpl. 2008;8(11):2185\u201391. \n                    https:\/\/doi.org\/10.1111\/j.1600-6143.2008.02385.x\n                    \n                  .","journal-title":"Am J Transpl."},{"issue":"4","key":"1769_CR9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/(SICI)1097-0215(19970516)71:4<517::AID-IJC3>3.0.CO;2-X","volume":"71","author":"Y Hoshida","year":"1997","unstructured":"Hoshida Y, Tsukuma H, Yasunaga Y, Xu N, Fujita MQ, Satoh T, et al. Cancer risk after renal transplantation in Japan. Int J Cancer. 1997;71(4):517\u201320.","journal-title":"Int J Cancer."},{"issue":"6","key":"1769_CR10","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s00595-018-1628-9","volume":"48","author":"T Miyazaki","year":"2018","unstructured":"Miyazaki T, Sato S, Kondo T, Kusaka M, Gotoh M, Saiki Y, et al. National survey of de novo malignancy after solid organ transplantation in Japan. Surg Today. 2018;48(6):618\u201324. \n                    https:\/\/doi.org\/10.1007\/s00595-018-1628-9\n                    \n                  .","journal-title":"Surg Today."},{"issue":"9","key":"1769_CR11","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/j.1432-2277.2012.01521.x","volume":"25","author":"C Courivaud","year":"2012","unstructured":"Courivaud C, Bamoulid J, Gaugler B, Roubiou C, Arregui C, Chalopin JM, et al. Cytomegalovirus exposure, immune exhaustion and cancer occurrence in renal transplant recipients. Transpl Int. 2012;25(9):948\u201355. \n                    https:\/\/doi.org\/10.1111\/j.1432-2277.2012.01521.x\n                    \n                  .","journal-title":"Transpl Int."},{"issue":"5","key":"1769_CR12","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/TP.0b013e318299dc0e","volume":"96","author":"EC Hall","year":"2013","unstructured":"Hall EC, Engels EA, Montgomery RA, Segev DL. Cancer risk after ABO-incompatible living-donor kidney transplantation. Transplantation. 2013;96(5):476\u20139. \n                    https:\/\/doi.org\/10.1097\/TP.0b013e318299dc0e\n                    \n                  .","journal-title":"Transplantation"},{"issue":"2","key":"1769_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000013314","volume":"18","author":"S Vamvakas","year":"1998","unstructured":"Vamvakas S, Bahner U, Heidland A. Cancer in end-stage renal disease: potential factors involved-editorial. Am J Nephrol. 1998;18(2):89\u201395. \n                    https:\/\/doi.org\/10.1159\/000013314\n                    \n                  .","journal-title":"Am J Nephrol."},{"issue":"12","key":"1769_CR14","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/sj.ki.5002154","volume":"71","author":"CD Wimmer","year":"2007","unstructured":"Wimmer CD, Rentsch M, Crispin A, Illner WD, Arbogast H, Graeb C, et al. The janus face of immunosuppression\u2014de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich. Kidney Int. 2007;71(12):1271\u20138. \n                    https:\/\/doi.org\/10.1038\/sj.ki.5002154\n                    \n                  .","journal-title":"Kidney Int."},{"issue":"8","key":"1769_CR15","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.2165\/00003495-200767080-00006","volume":"67","author":"A Gutierrez-Dalmau","year":"2007","unstructured":"Gutierrez-Dalmau A, Campistol JM. Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review. Drugs. 2007;67(8):1167\u201398.","journal-title":"Drugs."},{"issue":"1","key":"1769_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1067\/mlc.2001.111469","volume":"137","author":"M Herman","year":"2001","unstructured":"Herman M, Weinstein T, Korzets A, Chagnac A, Ori Y, Zevin D, et al. Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients. J Lab Clin Med. 2001;137(1):14\u201320. \n                    https:\/\/doi.org\/10.1067\/mlc.2001.111469\n                    \n                  .","journal-title":"J Lab Clin Med."},{"issue":"16","key":"1769_CR17","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.2165\/11319260-000000000-00000","volume":"69","author":"R Marcen","year":"2009","unstructured":"Marcen R. Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection. Drugs. 2009;69(16):2227\u201343. \n                    https:\/\/doi.org\/10.2165\/11319260-000000000-00000\n                    \n                  .","journal-title":"Drugs."},{"issue":"1","key":"1769_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.12659\/AOT.882649","volume":"17","author":"B Einollahi","year":"2012","unstructured":"Einollahi B. Malignancy after kidney transplantation. Ann Transpl. 2012;17(1):145\u20136.","journal-title":"Ann Transpl."},{"issue":"3","key":"1769_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/TP.0b013e3182247ae2","volume":"92","author":"J Alberu","year":"2011","unstructured":"Alberu J, Pascoe MD, Campistol JM, Schena FP, Rial Mdel C, Polinsky M, et al. Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-month results from the CONVERT trial. Transplantation. 2011;92(3):303\u201310. \n                    https:\/\/doi.org\/10.1097\/TP.0b013e3182247ae2\n                    \n                  .","journal-title":"Transplantation"},{"issue":"5","key":"1769_CR20","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1681\/asn.2009101043","volume":"21","author":"MP Gallagher","year":"2010","unstructured":"Gallagher MP, Kelly PJ, Jardine M, Perkovic V, Cass A, Craig JC, et al. Long-term cancer risk of immunosuppressive regimens after kidney transplantation. J Am Soc Nephrol. 2010;21(5):852\u20138. \n                    https:\/\/doi.org\/10.1681\/asn.2009101043\n                    \n                  .","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"1769_CR21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.trre.2007.12.004","volume":"22","author":"G Wong","year":"2008","unstructured":"Wong G, Chapman JR. Cancers after renal transplantation. Transpl Rev. 2008;22(2):141\u20139. \n                    https:\/\/doi.org\/10.1016\/j.trre.2007.12.004\n                    \n                  .","journal-title":"Transpl Rev"},{"issue":"Suppl 3","key":"1769_CR22","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","volume":"9","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transpl. 2009;9(Suppl 3):S1\u2013155. \n                    https:\/\/doi.org\/10.1111\/j.1600-6143.2009.02834.x\n                    \n                  .","journal-title":"Am J Transpl"},{"issue":"1","key":"1769_CR23","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/TP.0b013e31827743b4","volume":"95","author":"G Wong","year":"2013","unstructured":"Wong G, Turner RM, Chapman JR, Howell M, Lim WH, Webster AC, et al. Time on dialysis and cancer risk after kidney transplantation. Transplantation. 2013;95(1):114\u201321. \n                    https:\/\/doi.org\/10.1097\/TP.0b013e31827743b4\n                    \n                  .","journal-title":"Transplantation"},{"issue":"2","key":"1769_CR24","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/ncponc0081","volume":"2","author":"SF Moss","year":"2005","unstructured":"Moss SF, Blaser MJ. Mechanisms of disease: inflammation and the origins of cancer. Nat Clin Pract Oncol. 2005;2(2):90\u20137. \n                    https:\/\/doi.org\/10.1038\/ncponc0081\n                    \n                  \n                           (quiz 1 p following 113).","journal-title":"Nat Clin Pract Oncol."},{"key":"1769_CR25","doi-asserted-by":"publisher","first-page":"456","DOI":"10.12659\/AOT.890706","volume":"19","author":"K Vrotniakaite","year":"2014","unstructured":"Vrotniakaite K, Jaceviciute R, Rudminiene I, Laucyte-Cibulskiene A, Rainiene T, Jankevicius F, et al. Malignancy after renal transplantation: a single-center experience. Ann Transpl. 2014;19:456\u201363.","journal-title":"Ann Transpl."},{"issue":"2","key":"1769_CR26","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.transproceed.2008.12.013","volume":"41","author":"W Bichari","year":"2009","unstructured":"Bichari W, Bartiromo M, Mohey H, Afiani A, Burnot A, Maillard N, et al. Significant risk factors for occurrence of cancer after renal transplantation: a single center cohort study of 1265 cases. Transpl Proc. 2009;41(2):672\u20133. \n                    https:\/\/doi.org\/10.1016\/j.transproceed.2008.12.013\n                    \n                  .","journal-title":"Transpl Proc."},{"issue":"2","key":"1769_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/cam4.568","volume":"5","author":"T Kato","year":"2016","unstructured":"Kato T, Kakuta Y, Abe T, Yamanaka K, Imamura R, Okumi M, et al. The benefits of cancer screening in kidney transplant recipients: a single-center experience. Cancer Med. 2016;5(2):153\u20138. \n                    https:\/\/doi.org\/10.1002\/cam4.568\n                    \n                  .","journal-title":"Cancer Med."},{"key":"1769_CR28","doi-asserted-by":"publisher","first-page":"814973","DOI":"10.1155\/2013\/814973","volume":"2013","author":"M Mynarek","year":"2013","unstructured":"Mynarek M, Schober T, Behrends U, Maecker-Kolhoff B. Posttransplant lymphoproliferative disease after pediatric solid organ transplantation. Clin Dev Immunol. 2013;2013:814973. \n                    https:\/\/doi.org\/10.1155\/2013\/814973\n                    \n                  .","journal-title":"Clin Dev Immunol."}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-019-01769-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-019-01769-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-019-01769-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:14:41Z","timestamp":1596154481000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-019-01769-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,1]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["1769"],"URL":"https:\/\/doi.org\/10.1007\/s10157-019-01769-8","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,1]]},"assertion":[{"value":"25 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No potential conflicts of interest were disclosed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study. Written informed consents were obtained from all subjects for publication of this study. A copies of the written consent are available for review upon requests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional at which the studies were conducted (Medical Review Board of Gifu University, Graduate School of Medicine; No. 2018-015) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}